- Bevorzugter Name
- 2-[1-[2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide
- IUPAC
- 2-[1-[2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide
- Englischer Name
- 1-[2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]-α,α-diphenyl-
- Summenformel
- C28H32N2O3
- Molmasse
- 444.57
Namen und Synonyme
215032-24-92-[1-[2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide1-[2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]-alpha,alpha-diphenyl-2-(1-{2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl}pyrrolidin-3-yl)-2,2-diphenylacetamideDarifenacin Impurity 12 (UK-156961)1-[2-[4-HYDROXY-3-(2-HYDROXYETHYL)PHENYL]ETHYL]-ALPHA,ALPHA-DIPHENYL-3-PYRROLIDINEACETAMIDEDTXSID008577781-[2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]-|A,|A-diphenyl-3-pyrrolidineacetamide2-(1-(4-Hydroxy-3-(2-hydroxyethyl)phenethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide1-[2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]-?,?-diphenyl-3-pyrrolidineacetamideUK-156961UK- 156961
Weitere Namen anzeigen
DarifecinImpurity12Darifenacin ImpurityDarfinacin Impurity2Darfinacin Impurity1509Darifenacin IMpurity (UK-156961)1-[2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]-α,α-diphenyl-3-pyrrolidineacetamide